Cover Image
市場調查報告書

心臟移植的開發中產品分析

Heart Transplantation - Pipeline Review, H1 2015

出版商 Global Markets Direct 商品編碼 255978
出版日期 內容資訊 英文 32 Pages
訂單完成後即時交付
價格
Back to Top
心臟移植的開發中產品分析 Heart Transplantation - Pipeline Review, H1 2015
出版日期: 2015年04月15日 內容資訊: 英文 32 Pages
簡介

心臟移植是用適合的捐贈者所提供的另一顆心臟來代替病人原本功能衰退的心臟的手術。一般都是針對鬱血性心臟病(CHF)末期,如果不移植心臟恐怕活不過一年,也沒有其他治療法(或是其他治療法無效)的患者所用的手術。心臟移植的年平均頻率,約佔心臟衰竭患者整體(移植對象/非移植患者雙方)的1%。藉由改善CHF相關的醫療管理,縮小了移植對象患者人口數。但提供移植用心臟的可能性還是一樣重大的課題。

本報告提供全球各國治療心臟移植的開發中產品開發狀況分析,提供開發中產品的最新趨勢,及臨床實驗各階段的產品一覽,再加上主要企業簡介,主要藥物概要,最新的產業趨勢等調查,並將結果概述為以下內容。

簡介

  • 分析範圍

心臟移植概要

治療藥的開發

  • 心臟移植用開發中產品:概要
  • 心臟移植用開發中產品:比較分析

各企業開發中的心臟移植治療藥

開發中產品的概要

  • 初期階段的產品

心臟移植相關治療藥:開發中的產品一覽(各企業)

參與心臟移植相關治療藥開發的企業

  • Merck & Co., Inc.
  • Astellas Pharma Inc.
  • Portola Pharmaceuticals, Inc.
  • Viron Therapeutics, Inc.
  • NasVax Ltd.
  • ToleroTech Inc.

心臟移植:治療藥的評估

  • 單劑治療藥的情況
  • 標的別
  • 各行動機制
  • 各投藥法
  • 分子的各類型
  • 各治療分類

藥物簡介

  • VT-111a
    • 產品概要
    • 功能機制
    • 研究開發(R&D)的發展情形
  • Anti-CD3 Mab
  • JAK3 Specific抑制劑
  • AS-2521780
  • siRejection
  • JAK-3/1抑制劑
  • SCH-546738

心臟移植相關治療藥:最新的藥物簡介

心臟移植相關治療藥:開發暫停的產品

心臟移植相關產品的開發的里程碑

  • 值得注意的最新趨勢·新聞稿(全5件)

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC6659IDB

Summary

Global Markets Direct's, 'Heart Transplantation - Pipeline Review, H1 2015', provides an overview of the Heart Transplantation's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Heart Transplantation, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Heart Transplantation and special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Heart Transplantation
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Heart Transplantation and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Heart Transplantation products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Heart Transplantation pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products

Reasons to buy

  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Heart Transplantation
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Heart Transplantation pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Global Markets Direct Report Coverage
  • Heart Transplantation Overview
  • Therapeutics Development
    • Pipeline Products for Heart Transplantation - Overview
    • Pipeline Products for Heart Transplantation - Comparative Analysis
  • Heart Transplantation - Therapeutics under Development by Companies
  • Heart Transplantation - Therapeutics under Investigation by Universities/Institutes
  • Heart Transplantation - Pipeline Products Glance
    • Early Stage Products
  • Heart Transplantation - Products under Development by Companies
  • Heart Transplantation - Products under Investigation by Universities/Institutes
  • Heart Transplantation - Companies Involved in Therapeutics Development
    • Astellas Pharma Inc.
    • Merck & Co., Inc.
    • Viron Therapeutics, Inc.
  • Heart Transplantation - Therapeutics Assessment
    • Assessment by Monotherapy Products
    • Assessment by Target
    • Assessment by Mechanism of Action
    • Assessment by Molecule Type
  • Drug Profiles
    • AS-2521780 - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SCH-546738 - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Inhibit C-Rel for Central Nervous System, Immunology, Musculoskeletal, Oncology, Respiratory and Metabolic Disorders - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • VT-111a - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • VT-214 - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Heart Transplantation - Recent Pipeline Updates
  • Heart Transplantation - Dormant Projects
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Number of Products under Development for Heart Transplantation, H1 2015
  • Number of Products under Development for Heart Transplantation - Comparative Analysis, H1 2015
  • Number of Products under Development by Companies, H1 2015
  • Number of Products under Investigation by Universities/Institutes, H1 2015
  • Comparative Analysis by Early Stage Development, H1 2015
  • Products under Development by Companies, H1 2015
  • Products under Investigation by Universities/Institutes, H1 2015
  • Heart Transplantation - Pipeline by Astellas Pharma Inc., H1 2015
  • Heart Transplantation - Pipeline by Merck & Co., Inc., H1 2015
  • Heart Transplantation - Pipeline by Viron Therapeutics, Inc., H1 2015
  • Assessment by Monotherapy Products, H1 2015
  • Number of Products by Stage and Target, H1 2015
  • Number of Products by Stage and Mechanism of Action, H1 2015
  • Number of Products by Stage and Molecule Type, H1 2015
  • Heart Transplantation Therapeutics - Recent Pipeline Updates, H1 2015
  • Heart Transplantation - Dormant Projects, H1 2015

List of Figures

  • Number of Products under Development for Heart Transplantation - Comparative Analysis, H1 2015
  • Comparative Analysis by Early Stage Products, H1 2015
  • Number of Products by Top 10 Targets, H1 2015
  • Number of Products by Stage and Top 10 Targets, H1 2015
  • Number of Products by Top 10 Mechanism of Actions, H1 2015
  • Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015
  • Number of Products by Top 10 Molecule Types, H1 2015
Back to Top